Literature DB >> 34711737

Telemedicine and visit completion among people with HIV during the coronavirus disease 2019 pandemic compared with prepandemic.

Walid G El-Nahal1, Nicola M Shen2, Jeanne C Keruly1, Joyce L Jones1, Anthony T Fojo1, Bryan Lau2, Yukari C Manabe1, Richard D Moore1, Kelly A Gebo1, Catherine R Lesko2, Geetanjali Chander1.   

Abstract

OBJECTIVES: Telemedicine became the primary mode of delivering care during the COVID-19 pandemic. We describe the impact of telemedicine on access to care for people with HIV (PWH) by comparing the proportion of PWH engaged in care prior to and during the COVID-19 pandemic. DESIGN AND METHODS: We conducted an observational analysis of patients enrolled in the Johns Hopkins HIV Clinical Cohort, a single-center cohort of patients at an urban HIV subspecialty clinic affiliated with an academic center. Due to the COVID-19 pandemic, the clinic transitioned from in-person to mostly telemedicine visits. We compared patients receiving care in two time periods. The prepandemic period included 2010 people with at least one visit scheduled between 1 September 2019 and 15 March 2020. The pandemic period included 1929 people with at least one visit scheduled between 16 March 2020 and 30 September 2020. We determined the proportion of patients completing at least one of their scheduled visits during each period.
RESULTS: Visit completion increased significantly from 88% prepandemic to 91% during the pandemic (P = 0.008). Visit completion improved significantly for patients age 20-39 (82 to 92%, P < 0.001), women (86 to 93%, P < 0.001), Black patients (88 to 91%, P = 0.002) and patients with detectable viremia (77 to 85%, P = 0.06) during the pandemic. Only 29% of people who completed at least one telemedicine visit during the pandemic did so as a video (versus telephone) visit.
CONCLUSION: During the pandemic when care was widely delivered via telemedicine, visit completion improved among groups with lower prepandemic engagement but most were limited to telephone visits.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34711737      PMCID: PMC8795480          DOI: 10.1097/QAD.0000000000003119

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  32 in total

1.  Statistical analysis of correlated data using generalized estimating equations: an orientation.

Authors:  James A Hanley; Abdissa Negassa; Michael D deB Edwardes; Janet E Forrester
Journal:  Am J Epidemiol       Date:  2003-02-15       Impact factor: 4.897

2.  Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort.

Authors:  R D Moore
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

3.  How Structural Racism Works - Racist Policies as a Root Cause of U.S. Racial Health Inequities.

Authors:  Zinzi D Bailey; Justin M Feldman; Mary T Bassett
Journal:  N Engl J Med       Date:  2020-12-16       Impact factor: 91.245

4.  HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable.

Authors:  Robert W Eisinger; Carl W Dieffenbach; Anthony S Fauci
Journal:  JAMA       Date:  2019-02-05       Impact factor: 56.272

5.  Statistics, Adjusted Statistics, and Maladjusted Statistics.

Authors:  Jay S Kaufman
Journal:  Am J Law Med       Date:  2017-05

6.  Exploring Privilege in the Digital Divide: Implications for Theory, Policy, and Practice.

Authors:  Mei Lan Fang; Sarah L Canham; Lupin Battersby; Judith Sixsmith; Mineko Wada; Andrew Sixsmith
Journal:  Gerontologist       Date:  2019-01-09

7.  Measuring retention in HIV care: the elusive gold standard.

Authors:  Michael J Mugavero; Andrew O Westfall; Anne Zinski; Jessica Davila; Mari-Lynn Drainoni; Lytt I Gardner; Jeanne C Keruly; Faye Malitz; Gary Marks; Lisa Metsch; Tracey E Wilson; Thomas P Giordano
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-15       Impact factor: 3.731

Review 8.  Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis.

Authors:  J Poorolajal; E Hooshmand; H Mahjub; N Esmailnasab; E Jenabi
Journal:  Public Health       Date:  2016-06-24       Impact factor: 2.427

9.  Advancing Digital Health Equity: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.

Authors:  Brian R Wood; Jeremy D Young; Rima C Abdel-Massih; Lewis McCurdy; Todd J Vento; Shireesha Dhanireddy; Kay J Moyer; Javeed Siddiqui; John D Scott
Journal:  Clin Infect Dis       Date:  2021-03-15       Impact factor: 9.079

Review 10.  HIV and COVID-19: Intersecting Epidemics With Many Unknowns.

Authors:  Catherine R Lesko; Angela M Bengtson
Journal:  Am J Epidemiol       Date:  2021-01-04       Impact factor: 4.897

View more
  6 in total

1.  Provider Perspectives on HIV Pre-Exposure Prophylaxis Service Disruptions and Adaptations During the COVID-19 Pandemic in Baltimore, Maryland: A Qualitative Study.

Authors:  Joseph G Rosen; Leanne Zhang; Danielle Pelaez; Jenell S Coleman; C To; Lyra Cooper; Praise F Olatunde; Teagan Toomre; Jennifer L Glick; Ju Nyeong Park
Journal:  AIDS Patient Care STDS       Date:  2022-08       Impact factor: 5.944

2.  Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort.

Authors:  Andrea De Vito; Annarita Botta; Marco Berruti; Valeria Castelli; Vincenzo Lai; Chiara Cassol; Alessandro Lanari; Giulia Stella; Adrian Shallvari; Antonia Bezenchek; Antonio Di Biagio
Journal:  J Pers Med       Date:  2022-01-31

3.  The Negative Impact of COVID-19 in HCV, HIV, and HPV Surveillance Programs During the Different Pandemic Waves.

Authors:  Beatriz Romero-Hernández; Laura Martínez-García; Mario Rodríguez-Dominguez; Javier Martínez-Sanz; Manuel Vélez-Díaz-Pallarés; Belen Pérez Mies; A Muriel; Francisco Gea; María Jesús Pérez-Elías; Juan Carlos Galán
Journal:  Front Public Health       Date:  2022-07-22

Review 4.  Impact of the COVID-19 Pandemic on HIV Healthcare Service Engagement, Treatment Adherence, and Viral Suppression in the United States: A Systematic Literature Review.

Authors:  Sarah E Slone; Oluwabunmi Ogungbe; Brenice Duroseau; Diane Meyer; Jason E Farley
Journal:  AIDS Behav       Date:  2022-08-02

5.  Exploration of a Mobile Technology Vulnerability Scale's association with antiretroviral adherence among young adults living with HIV in the United States.

Authors:  Parya Saberi; Shadi Eskaf; Chadwick K Campbell; Torsten B Neilands; John A Sauceda; Karine Dubé
Journal:  Mhealth       Date:  2022-07-20

6.  COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts.

Authors:  Catherine R Lesko; Jeanne C Keruly; Richard D Moore; Nicola M Shen; Jarratt D Pytell; Bryan Lau; Anthony T Fojo; Shruti H Mehta; Michele Kipke; Marianna K Baum; Steven Shoptaw; Pamina M Gorbach; Brian Mustanski; Marjan Javanbakht; Suzanne Siminski; Geetanjali Chander
Journal:  Drug Alcohol Depend       Date:  2022-02-12       Impact factor: 4.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.